New Search

Advanced search
Export article
Open Access

The Success of a Screening Program Is Largely Dependent on Close Collaboration between the Laboratory and the Clinical Follow-Up of the Patients

Svetlana Lajic, Leif Karlsson, Rolf H. Zetterström, Henrik Falhammar, Anna Nordenström
Published: 26 August 2020
 by  MDPI
International Journal of Neonatal Screening , Volume 6; doi:10.3390/ijns6030068

Abstract: Neonatal screening for congenital adrenal hyperplasia due to 21-hydroxylase deficiency is now performed in an increasing number of countries all over the world. The main goal of the screening is to achieve early diagnosis and treatment in order to prevent neonatal salt-crisis and death. The screening laboratory can also play an important role in increasing the general awareness of the disease and act as the source of information and education for clinicians to facilitate improved initial care, ensure prompt and correct glucocorticoid dosing to optimize the long-term outcome for the patients. A National CAH Registry and CYP21A2 genotyping provide valuable information both for evaluating the screening program and the clinical outcome. The Swedish experience is described.
Keywords: congenital adrenal hyperplasia / neonatal screening / 21-hydroxylase Deficiency / long-term outcome / CAH

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

Share this article

Click here to see the statistics on "International Journal of Neonatal Screening" .
References (53)
    Back to Top Top